Skip to main content

Advertisement

SpringerLink
Log in

Freeing the vessel from metallic cage: what can we achieve with bioresorbable vascular scaffolds?

  • Review Article
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Serruys PW, Daemen J. Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents. Circulation. 2007;115:1433–9. discussion 1439.

    Article  PubMed  Google Scholar 

  2. Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pinto IM, Seixas AC, Staico R, Mattos LA, Sousa AG, Falotico R, Jaeger J, Popma JJ, Serruys PW. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2001;103:192–5.

    Article  PubMed  CAS  Google Scholar 

  3. Rensing BJ, Vos J, Smits PC, Foley DP, van den Brand MJ, van der Giessen WJ, de Feijter PJ, Serruys PW. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J. 2001;22:2125–30.

    Article  PubMed  CAS  Google Scholar 

  4. Sousa JE, Costa MA, Abizaid AC, Rensing BJ, Abizaid AS, Tanajura LF, Kozuma K, Van Langenhove G, Sousa AG, Falotico R, Jaeger J, Popma JJ, Serruys PW. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation. 2001;104:2007–11.

    Article  PubMed  CAS  Google Scholar 

  5. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–80.

    Article  PubMed  CAS  Google Scholar 

  6. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435–41.

    Article  PubMed  Google Scholar 

  7. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193–202.

    Article  PubMed  Google Scholar 

  8. Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, Vogel R, Togni M, Wenaweser P, Billinger M, Seiler C, Gay S, Meier B, Pichler WJ, Juni P, Virmani R, Windecker S. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation. 2009;120:391–9.

    Article  PubMed  Google Scholar 

  9. Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, Ligthart JM, van Essen D, de Feyter PJ, Serruys PW. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J. 2006;27:166–70.

    Article  PubMed  Google Scholar 

  10. Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Billinger M, Meier B, Hess OM. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol. 2005;46:231–6.

    Article  PubMed  CAS  Google Scholar 

  11. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961–72.

    Article  PubMed  CAS  Google Scholar 

  12. Spuentrup E, Ruebben A, Mahnken A, Stuber M, Kolker C, Nguyen TH, Gunther RW, Buecker A. Artifact-free coronary magnetic resonance angiography and coronary vessel wall imaging in the presence of a new, metallic, coronary magnetic resonance imaging stent. Circulation. 2005;111:1019–26.

    Article  PubMed  Google Scholar 

  13. Ormiston JA, Serruys PW. Bioabsorbable coronary stents. Circ Cardiovasc Interv. 2009;2:255–60.

    Article  PubMed  CAS  Google Scholar 

  14. Kohsaka S, Kimura T, Goto M, Lee VV, Elayda M, Furukawa Y, Fukushima M, Komeda M, Sakata R, Willerson JT, Wilson JM, Kita T. Difference in patient profiles and outcomes in Japanese versus American patients undergoing coronary revascularization (collaborative study by credo-kyoto and the texas heart institute research database). Am J Cardiol. 2010;105:1698–704.

    Article  PubMed  Google Scholar 

  15. Network Jot. Number of organ transplantation after brain death; 2011. http://www.jotnw.or.jp/datafile/offer_brain.html.

  16. Wentzel JJ, Whelan DM, van der Giessen WJ, van Beusekom HM, Andhyiswara I, Serruys PW, Slager CJ, Krams R. Coronary stent implantation changes 3-d vessel geometry and 3-d shear stress distribution. J Biomech. 2000;33:1287–95.

    Article  PubMed  CAS  Google Scholar 

  17. Gyongyosi M, Yang P, Khorsand A, Glogar D. Longitudinal straightening effect of stents is an additional predictor for major adverse cardiac events. Austrian wiktor stent study group and European paragon stent investigators. J Am Coll Cardiol. 2000;35:1580–9.

    Article  PubMed  CAS  Google Scholar 

  18. Gomez-Lara J, Brugaletta S, Diletti R, Garg S, Onuma Y, Gogas BD, van Geuns RJ, Dorange C, Veldhof S, Rapoza R, Whitbourn R, Windecker S, Garcia-Garcia HM, Regar E, Serruys PW. A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds. Eur Heart J. 2011;32:294–304.

    Article  PubMed  CAS  Google Scholar 

  19. Gomez-Lara J, Garcia-Garcia HM, Onuma Y, Garg S, Regar E, De Bruyne B, Windecker S, McClean D, Thuesen L, Dudek D, Koolen J, Whitbourn R, Smits PC, Chevalier B, Dorange C, Veldhof S, Morel MA, de Vries T, Ormiston JA, Serruys PW. A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents. JACC Cardiovasc Interv. 2010;3:1190–8.

    Article  PubMed  Google Scholar 

  20. Thury A, Wentzel JJ, Vinke RV, Gijsen FJ, Schuurbiers JC, Krams R, de Feyter PJ, Serruys PW, Slager CJ. Images in cardiovascular medicine. Focal in-stent restenosis near step-up: roles of low and oscillating shear stress? Circulation. 2002;105:e185–7.

    Article  PubMed  Google Scholar 

  21. Cheng C, Tempel D, Oostlander A, Helderman F, Gijsen F, Wentzel J, van Haperen R, Haitsma DB, Serruys PW, van der Steen AF, de Crom R, Krams R. Rapamycin modulates the enos vs. Shear stress relationship. Cardiovasc Res. 2008;78:123–9.

    Article  PubMed  CAS  Google Scholar 

  22. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hebert K, Veldhof S, Webster M, Thuesen L, Dudek D. A bioabsorbable everolimus-eluting coronary stent system (absorb): 2-year outcomes and results from multiple imaging methods. Lancet. 2009;373:897–910.

    Article  PubMed  CAS  Google Scholar 

  23. Ciccone WJ 2nd, Motz C, Bentley C, Tasto JP. Bioabsorbable implants in orthopaedics: new developments and clinical applications. J Am Acad Orthop Surg. 2001;9:280–8.

    PubMed  Google Scholar 

  24. Resnick N, Yahav H, Shay-Salit A, Shushy M, Schubert S, Zilberman LC, Wofovitz E. Fluid shear stress and the vascular endothelium: for better and for worse. Prog Biophys Mol Biol. 2003;81:177–99.

    Article  PubMed  Google Scholar 

  25. Slager CJ, Wentzel JJ, Gijsen FJ, Schuurbiers JC, van der Wal AC, van der Steen AF, Serruys PW. The role of shear stress in the generation of rupture-prone vulnerable plaques. Nat Clin Pract Cardiovasc Med. 2005;2:401–7.

    Article  PubMed  CAS  Google Scholar 

  26. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S. A bioabsorbable everolimus-eluting coronary stent system for patients with single de novo coronary artery lesions (absorb): a prospective open-label trial. Lancet. 2008;371:899–907.

    Article  PubMed  CAS  Google Scholar 

  27. Serruys PW, Onuma Y, Dudek D, Smits PC, Koolen J, Chevalier B, Bruyne Bd, Thuesen L, McClean D, Geuns R-Jv, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Sudhir K, Garcia-Garcia HM, Ormiston JA. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol. 2011;58(15):1578–88.

  28. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular biology of the cell. Garland Science, New York; 2002.

  29. Cheng C, Noordeloos AM, Jeney V, Soares MP, Moll F, Pasterkamp G, Serruys PW, Duckers HJ. Heme oxygenase 1 determines atherosclerotic lesion progression into a vulnerable plaque. Circulation. 2009;119:3017–27.

    Article  PubMed  CAS  Google Scholar 

  30. Mueller MA, Beutner F, Teupser D, Ceglarek U, Thiery J. Prevention of atherosclerosis by the mtor inhibitor everolimus in ldlr−/− mice despite severe hypercholesterolemia. Atherosclerosis. 2008;198:39–48.

    Article  PubMed  CAS  Google Scholar 

  31. Lehoux S, Tedgui A. Cellular mechanics and gene expression in blood vessels. J Biomech. 2003;36:631–43.

    Article  PubMed  Google Scholar 

  32. Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, Komori H, Tsuji T, Motohara S, Uehata H. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation. 2000;102:399–404.

    Article  PubMed  CAS  Google Scholar 

  33. Tsuji T, Tamai H, Igaki K, Hsu Y-S, Kosuga K, Hata T, OKada M, Nakamura T, Fujita S. Four-year follow-up of the biodegradable stent (Igaki–Tamai stent). Circ J. 2004;68:135.

    Article  Google Scholar 

  34. Nishio S. Long-term (>10 years) clinical outcomes of first-in-man biodegradable poly-l-lactic acid coronary stents. In: EuroPCR; 2010.

  35. Post MJ, de Graaf-Bos AN, van Zanten HG, de Groot PG, Sixma JJ, Borst C. Thrombogenicity of the human arterial wall after interventional thermal injury. J Vasc Res. 1996;33:156–63.

    Article  PubMed  CAS  Google Scholar 

  36. Biamino G, Schmidt A, Scheinert D. Treatment of sfa lesions with plla biodegradable stents: results of the perseus study. J Endovasc Ther. 2005;12:5.

    Google Scholar 

  37. Yamawaki T, Shimokawa H, Kozai T, Miyata K, Higo T, Tanaka E, Egashira K, Shiraishi T, Tamai H, Igaki K, Takeshita A. Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo. J Am Coll Cardiol. 1998;32:780–6.

    Article  PubMed  CAS  Google Scholar 

  38. Erbel R, Di Mario C, Bartunek J, Bonnier J, de Bruyne B, Eberli FR, Erne P, Haude M, Heublein B, Horrigan M, Ilsley C, Bose D, Koolen J, Luscher TF, Weissman N, Waksman R. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet. 2007;369:1869–75.

    Article  PubMed  CAS  Google Scholar 

  39. Heublein B, Rohde R, Kaese V, Niemeyer M, Hartung W, Haverich A. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart. 2003;89:651–6.

    Article  PubMed  CAS  Google Scholar 

  40. Waksman R, Pakala R, Kuchulakanti PK, Baffour R, Hellinga D, Seabron R, Tio FO, Wittchow E, Hartwig S, Harder C, Rohde R, Heublein B, Andreae A, Waldmann KH, Haverich A. Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries. Catheter Cardiovasc Interv. 2006;68:607–17. discussion 618–9.

    Article  PubMed  Google Scholar 

  41. Peeters P, Bosiers M, Verbist J, Deloose K, Heublein B. Preliminary results after application of absorbable metal stents in patients with critical limb ischemia. J Endovasc Ther. 2005;12:1–5.

    Article  PubMed  Google Scholar 

  42. Waksman R, Erbel R, Di Mario C, Bartunek J, de Bruyne B, Eberli FR, Erne P, Haude M, Horrigan M, Ilsley C, Bose D, Bonnier H, Koolen J, Luscher TF, Weissman NJ. Early- and long-term intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries. JACC Cardiovasc Interv. 2009;2:312–20.

    Article  PubMed  Google Scholar 

  43. Eggebrecht H, Rodermann J, Hunold P, Schmermund A, Bose D, Haude M, Erbel R. Images in cardiovascular medicine. Novel magnetic resonance-compatible coronary stent: the absorbable magnesium-alloy stent. Circulation. 2005;112:e303–4.

    Article  PubMed  Google Scholar 

  44. Ghimire G, Spiro J, Kharbanda R, Roughton M, Barlis P, Mason M, Ilsley C, Di Mario C, Erbel R, Waksman R, Dalby M. Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents. EuroIntervention. 2009;4:481–4.

    Article  PubMed  Google Scholar 

  45. Bosiers M, Peeters P, D’Archambeau O, Hendriks J, Pilger E, Duber C, Zeller T, Gussmann A, Lohle PN, Minar E, Scheinert D, Hausegger K, Schulte KL, Verbist J, Deloose K, Lammer J. Ams insight-absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis. Cardiovasc Intervent Radiol. 2009;32:424–35.

    Article  PubMed  Google Scholar 

  46. Schulze R. Reva medical, inc. Bioresorbable stent. Cardiovascular Revascularization Therapies 2007. 2007.

  47. Schultz R. Reva medical, inc. Bioresorbable technology. CRT; 2006.

  48. Grube E. Bioabsorbable stent. The Boston scientific and reva technology. In: EuroPCR 2009. 2009.

  49. Ormiston JA, Webster MW, Armstrong G. First-in-human implantation of a fully bioabsorbable drug-eluting stent: The ABSORB poly-l-lactic acid everolimus-eluting coronary stent. Catheter Cardiovasc Interv. 2007;69:128–31.

    Article  PubMed  Google Scholar 

  50. Bruining N, Tanimoto S, Otsuka M, Weustink A, Lighthart J, Winter Sd, Mieghem Cv, Nieman K, Feijter PJd, Domburg RTv, Serruys PW. Quantitative multi-modality imaging analysis of a bioabsorbable poly-l-lactic acid stent design in the acute phase: a comparison between 2- and 3D-QCA, QCU and QMSCT-CA. EuroInterv. 2008;4:1–7.

    Article  Google Scholar 

  51. García-García HM, Gonzalo N, Pawar R, Kukreja N, Dudek D, Thuesen L, Ormiston JA, Regar E, Serruys PW. Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the absorb clinical trial. EuroIntervention. 2008;4:443–8.

    Article  Google Scholar 

  52. Tanimoto S, Bruining N, van Domburg RT, Rotger D, Radeva P, Ligthart JM, Serruys PW. Late stent recoil of the bioabsorbable everolimus-eluting coronary stent and its relationship with plaque morphology. J Am Coll Cardiol. 2008;52:1616–20.

    Article  PubMed  CAS  Google Scholar 

  53. Tanimoto S, Serruys PW, Thuesen L, Dudek D, de Bruyne B, Chevalier B, Ormiston JA. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: inssights from the absorb and spirit trials. Cathet Cardiovasc Interv. 2007;70(4):515–23.

    Google Scholar 

  54. Onuma Y, Serruys P, Ormiston J, Regar E, Webster M, Thuesen L, Dudek D, Veldhof S, Rapoza R. Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: The absorb trial. EuroIntervention. 2010;6(4):447–53.

    Google Scholar 

  55. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–51.

    Article  PubMed  Google Scholar 

  56. Okamura T, Garg S, Gutiérrez-Chico J, Shin E, Onuma Y, García-García H, Rapoza R, Sudhir K, Regar E, Serruys P. In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an oct ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the absorb clinical trial. EuroIntervention. 2010;5:932–38.

    Google Scholar 

  57. Serruys PW, Onuma Y, Ormiston JA, Bruyne Bd, Regar E, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Rapoza R, Garcia-Garcia HM. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: 6-month clinical and imaging outcomes. Circulation. 2010;122(22):2301–12.

  58. Yan J, Bhat VD. Elixir medical’s bioresorbable drug eluting stent (bdes) programme: an overview. EuroIntervention. 2009;5:F80–2.

    Article  PubMed  Google Scholar 

  59. Pendyala LK, Yin X, Li J, Chen JP, Chronos N, Hou D. The first-generation drug-eluting stents and coronary endothelial dysfunction. JACC Cardiovasc Interv. 2009;2:1169–77.

    Article  PubMed  Google Scholar 

  60. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KR, Quyyumi AA. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106:653–8.

    Article  PubMed  Google Scholar 

  61. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101:948–54.

    Article  PubMed  CAS  Google Scholar 

  62. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol. 1999;33:1442–52.

    Article  PubMed  CAS  Google Scholar 

  63. Shimokawa H. Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models. Jpn Circ J. 2000;64:1–12.

    Article  PubMed  CAS  Google Scholar 

  64. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med. 1993;328:1659–64.

    Article  PubMed  CAS  Google Scholar 

  65. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J. Validation of a doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation. 1992;85:1899–911.

    Article  PubMed  CAS  Google Scholar 

  66. Serruys PW, Zijlstra F, Laarman GJ, Reiber HH, Beatt K, Roelandt J. A comparison of two methods to measure coronary flow reserve in the setting of coronary angioplasty: intracoronary blood flow velocity measurements with a doppler catheter, and digital subtraction cineangiography. Eur Heart J. 1989;10:725–36.

    PubMed  CAS  Google Scholar 

  67. Bruining N, Tanimoto S, Otsuka M, Weustink A, Ligthart J, de Winter S, van Mieghem C, Nieman K, de Feyter PJ, van Domburg RT, Serruys PW. Quantitative multi-modality imaging analysis of a bioabsorbable poly-l-lactic acid stent design in the acute phase: a comparison between 2- and 3D-QCA, QCU and QMSCT-CA. EuroIntervention. 2008;4:285–91.

    Article  PubMed  Google Scholar 

  68. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667–78.

    Article  PubMed  CAS  Google Scholar 

  69. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schomig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabate M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Juni P. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007;370:937–48.

    Article  PubMed  CAS  Google Scholar 

  70. Serruys PW, Onuma Y, Dudek D, Smits PC, Koolen J, Chevalier B, de Bruyne B, Thuesen L, McClean D, van Geuns RJ, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Sudhir K, Garcia-Garcia HM, Ormiston JA. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol. 2011;58:1578–88.

    Article  PubMed  CAS  Google Scholar 

  71. Hahn C, Schwartz MA. Mechanotransduction in vascular physiology and atherogenesis. Natl Rev Mol Cell Biol. 2009;10:53–62.

    Article  CAS  Google Scholar 

  72. Gupta V, Grande-Allen KJ. Effects of static and cyclic loading in regulating extracellular matrix synthesis by cardiovascular cells. Cardiovasc Res. 2006;72:375–83.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Thoraxcenter, Erasmus Medical Center, ‘s Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands

    Yoshinobu Onuma, Takashi Muramatsu, Alexander Kharlamov & Patrick W. Serruys

Authors
  1. Yoshinobu Onuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Muramatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander Kharlamov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrick W. Serruys
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick W. Serruys.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Onuma, Y., Muramatsu, T., Kharlamov, A. et al. Freeing the vessel from metallic cage: what can we achieve with bioresorbable vascular scaffolds?. Cardiovasc Interv and Ther 27, 141–154 (2012). https://doi.org/10.1007/s12928-012-0101-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-012-0101-8

Keywords

Search

Navigation